Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Corium International Inc (CORI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3472
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products include Corplex Memantine and Corplex Donepezil for the treatment of Alzheimer’s disease. Corium also develops MicroCor PTH for the treatment of osteoporosis using another technology platform called MicroCor system. The company provides proprietary development programs, contract research and development services. It partners with pharmaceutical and consumer products companies. The company operates through its research and development facility in Grand Rapids, the US. Corium is headquartered in Menlo Park, California, the US.

Corium International Inc (CORI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corium International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corium International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Corium International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Corium International Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Aequus Pharma Enters into Co-Development Agreement with Corium International 11
Aequus Pharma Enters into Co-Development Agreement with Corium International 12
Equity Offering 13
Corium Plans to Raise USD150 Million in Public Offering of Securities 13
Corium International Raises USD40.3 Million in Public Offering of Shares 14
Corium International Raises USD20 Million in Public Offering of Shares 16
Corium International Raises USD52 Million in Public Offering of Shares 17
Debt Offering 19
Corium International Prices Private Placement of Notes Due 2025 for USD100 Million 19
Corium International Inc – Key Competitors 20
Corium International Inc – Key Employees 21
Corium International Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 09, 2018: Corium International announces third quarter fiscal 2018 financial results 23
May 14, 2018: Corium Announces Second Quarter Fiscal 2018 Financial Results 25
Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights 26
Nov 16, 2017: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights 27
Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 29
May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights 30
Feb 13, 2017: Corium Reports First Quarter Fiscal 2017 Financial Results 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Corium International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corium International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corium International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Corium International Inc, Medical Devices Deals, 2012 to YTD 2018 9
Corium International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aequus Pharma Enters into Co-Development Agreement with Corium International 11
Aequus Pharma Enters into Co-Development Agreement with Corium International 12
Corium Plans to Raise USD150 Million in Public Offering of Securities 13
Corium International Raises USD40.3 Million in Public Offering of Shares 14
Corium International Raises USD20 Million in Public Offering of Shares 16
Corium International Raises USD52 Million in Public Offering of Shares 17
Corium International Prices Private Placement of Notes Due 2025 for USD100 Million 19
Corium International Inc, Key Competitors 20
Corium International Inc, Key Employees 21
Corium International Inc, Other Locations 22

List of Figures
Corium International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Corium International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Corium International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Corium International Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Mengniu Dairy Co Ltd:企業の戦略・SWOT・財務情報
    China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Mengniu Dairy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CAS Medical Systems Inc (CASM):企業の財務・戦略的SWOT分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Pentair plc (PNR)-石油・ガス分野:企業M&A・提携分析
    Summary Pentair plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water system products and solutions for filtration, separation and fluid process management; and products that guard sensitive electrical and electronic equipment; and heat management solutions …
  • The Hongkong and Shanghai Hotels Ltd:企業の戦略・SWOT・財務情報
    The Hongkong and Shanghai Hotels Ltd - Strategy, SWOT and Corporate Finance Report Summary The Hongkong and Shanghai Hotels Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • SCB Life Assurance Public Company Limited:戦略・SWOT・企業財務分析
    SCB Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary SCB Life Assurance Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • RCM Technologies Inc (RCMT):企業の財務・戦略的SWOT分析
    RCM Technologies Inc (RCMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • A-Mark Precious Metals Inc (AMRK):企業の財務・戦略的SWOT分析
    A-Mark Precious Metals Inc (AMRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Huadian Power International Corporation Ltd (1071):企業の財務・戦略的SWOT分析
    Huadian Power International Corporation Ltd (1071) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Altona Energy Plc:企業の戦略・SWOT・財務情報
    Altona Energy Plc - Strategy, SWOT and Corporate Finance Report Summary Altona Energy Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Amscan Holdings, Inc.:企業の戦略・SWOT・財務情報
    Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amscan Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FLIR Systems Inc:企業のM&A・事業提携・投資動向
    FLIR Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FLIR Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Bone Therapeutics SA (BOTHE):企業の財務・戦略的SWOT分析
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. It offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and AL …
  • Shanghai Electric Power Co Ltd (600021):企業の財務・戦略的SWOT分析
    Summary Shanghai Electric Power Co., Ltd. (Shanghai Electric Power), a subsidiary of State Power Investment Corporation is an electric energy company that generates and supplies electricity and thermal power. The company generates electricity from coal-fired plants, gas-fired plants, IGCC, gas power …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Supernus Pharmaceuticals Inc (SUPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …
  • Altavia SA:企業の戦略的SWOT分析
    Altavia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • BioClin Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioClin Therapeutics Inc (BioClin) is a clinical stage biotechnology company developing protein therapeutics for genetic disorders. Its lead product candidate B-701 is a human monoclonal antibody which targets the activity of FGFR3 (fibroblast growth factor receptor 3) and does not interact …
  • Valneva SE (VLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …
  • Farouk Systems, Inc:企業の戦略・SWOT・財務情報
    Farouk Systems, Inc - Strategy, SWOT and Corporate Finance Report Summary Farouk Systems, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆